Cargando…

Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1

The prevalence of nonalcoholic fatty liver disease (NAFLD) is usually increased with age. Non-alcoholic steatohepatitis (NASH), a serious form of NAFLD, may lead to cirrhosis and end-stage liver diseases. Induced pluripotent stem cells (iPSCs) hold promising potential in personalized medicine. Altho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chien, Yueh, Huang, Chi-Shuan, Lin, Hsin-Chi, Lu, Kai-Hsi, Tsai, Ping-Hsing, Lai, Ying-Hsiu, Chen, Kuan-Hsuan, Lee, Shou-Dong, Huang, Yi-Hsiang, Wang, Chien-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915096/ https://www.ncbi.nlm.nih.gov/pubmed/29719629 http://dx.doi.org/10.18632/oncotarget.23603

Ejemplares similares

Manipulation of KLF4 Expression Generates iPSCs Paused at Successive Stages of Reprogramming
por: Nishimura, Ken, et al.
Publicado: (2014)

Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs
por: Velychko, Sergiy, et al.
Publicado: (2019)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Application of the Yamanaka Transcription Factors Oct4, Sox2, Klf4, and c-Myc from the Laboratory to the Clinic
por: Aguirre, Marisol, et al.
Publicado: (2023)

Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer
por: Hong, Liwei, et al.
Publicado: (2023)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms
por: Cai, Yanning, et al.
Publicado: (2015)

Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4
por: Corbineau, Sébastien, et al.
Publicado: (2016)

Evaluation of the Effect of Orlistatorlistat on Expression of OCT4, Nanog, SOX2, and KLF4 Genes in Colorectal Cancer SW40 Cell Line
por: Noroozi Karimabad, Mojgan, et al.
Publicado: (2021)

Counteracting Activities of OCT4 and KLF4 during Reprogramming to Pluripotency
por: Tiemann, Ulf, et al.
Publicado: (2014)

Expression profiling of cell-intrinsic regulators in the process of differentiation of human iPSCs into retinal lineages
por: Chuang, Jen-Hua, et al.
Publicado: (2018)

The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation
por: Schmidt, Ryan, et al.
Publicado: (2012)

Increases in iPS Transcription Factor (Oct4, Sox2, c-Myc, and Klf4) Gene Expression after Modified Electroconvulsive Therapy
por: Nishiguchi, Masaki, et al.
Publicado: (2015)

PARP1 controls KLF4-mediated telomerase expression in stem cells and cancer cells
por: Hsieh, Meng-Hsun, et al.
Publicado: (2017)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

Overexpression of the transcription factors OCT4 and KLF4 improves motor function after spinal cord injury
por: Huang, Xianpeng, et al.
Publicado: (2020)

iPSCs derived from esophageal atresia patients reveal SOX2 dysregulation at the anterior foregut stage
por: Raad, Suleen, et al.
Publicado: (2022)

microRNA-690 regulates induced pluripotent stem cells (iPSCs) differentiation into insulin-producing cells by targeting Sox9
por: Xu, Yang, et al.
Publicado: (2019)

Human fibroblasts facilitate the generation of iPSCs-derived mammary-like organoids
por: Dai, Xueqin, et al.
Publicado: (2022)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

Expression of SOX2 and OCT4 in odontogenic cysts and tumors
por: Phattarataratip, Ekarat, et al.
Publicado: (2021)

Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study
por: Grande, Giuseppe, et al.
Publicado: (2019)

The spontaneous differentiation and chromosome loss in iPSCs of human trisomy 18 syndrome
por: Li, Ting, et al.
Publicado: (2017)

Engineered zinc-finger transcription factors activate OCT4 (POU5F1), SOX2, KLF4, c-MYC (MYC) and miR302/367
por: Ji, Qingzhou, et al.
Publicado: (2014)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

The tale of autologous iPSCs: A monkey perspective
por: Li, Fei
Publicado: (2014)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Functional genomics and the future of iPSCs in disease modeling
por: Brooks, Imogen R., et al.
Publicado: (2022)

Modelling urea cycle disorders using iPSCs
por: Duff, Claire, et al.
Publicado: (2022)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f00lppv1v2kp5ko3g45qardtn6